TAG:
outreach lab
How PAML Built a Major Business In Lab Joint Ventures with Hospitals
By Robert Michel | From the Volume XIV No. 17 – December 10, 2007 Issue
“A well-structured laboratory joint venture helps the hospital partner tap the unrealized value of its laboratory, because the independent lab partner provides capital, along with experience, and expertise to s…
Recognizing Laboratory Leadership
By R. Lewis Dark | From the Volume XIV No. 9 – June 25, 2007 Issue
WHEN LABORATORY CORPORATION OF AMERICA CLOSES ON THE SALE and becomes the owner of DSI Laboratories, Inc., of Fort Meyers, Florida, it will mark the end of one of the nation’s oldest hospital laboratory outreach programs. I consider this to be a good news/bad news…
DSI Sale Shows Value of Lab Outreach Program
By Robert Michel | From the Volume XIV No. 9 – June 25, 2007 Issue
CEO SUMMARY: For other hospital laboratory outreach programs, the pending sale of DSI Laboratories, Inc., of Fort Meyers, Florida, to Laboratory Corporation of America provides useful insights about the market value of these programs. Applying general formulas for determining a sales pric…
Community Hospital Builds Thriving Lab Outreach Program
By Robert Michel | From the Volume XIV No. 8 – June 4, 2007 Issue
CEO SUMMARY: When 330-bed Botsford Hospital of Farmington Hills, Michigan, got interested in laboratory outreach 10 years ago, it brought in a new laboratory leader, invested in new analyzers and informatics, and then let the quality of the operation attract new business from the communit…
Labs Need Response to Physicians’ Use of EMR
By Robert Michel | From the Volume XIII No. 16 – November 27, 2006 Issue
CEO SUMMARY: A new trend is emerging in outreach laboratory IT systems. Labs are linking to the electronic medical record (EMR) systems in their physician clients’ offices. Delivering lab results to these systems is already common. Enabling electronic order entry is the next wave. Clini…
Middleware Provides Opportunity For Labs to Gain New Functions
By Robert Michel | From the Volume XII No. 17 – December 5, 2005 Issue
“Even as more laboratories begin to use middleware, the number of functions and uses for middleware continues to increase —Gregory R Vail, CEO, Data Innovations, Inc. CEO SUMMARY: Middleware is attracting attention throughout the laboratory ind…
Picking Winners and Losers For the Molecular Test Menu
By Robert Michel | From the Volume XII No. 12 – August 22, 2005 Issue
CEO SUMMARY: In the 15 years it has operated a molecular diagnostics testing program, Beaumont Reference Laboratory (BRL) has learned important lessons on how to evaluate which specific molecular assays are ready for clinical introduction. It has also learned effective ways to anticipate …
Molecular Diagnostics: How Beaumont Built A Successful Program
By Robert Michel | From the Volume XII No. 11 – August 1, 2005 Issue
CEO SUMMARY: It was about 15 years ago when William Beaumont Hospital and Beaumont Reference Laboratories first began offering molecular diagnostic testing services to clinicians. This successful effort came about because of effective strategic planning, use of consulting expertise at key…
FL Medicaid Gives Up On Statewide Lab Contract
By Robert Michel | From the Volume XII No. 4 – March 7, 2005 Issue
CEO SUMMARY: With the withdrawal of the December 13, 2004 “Invitation to Negotiate” (ITN), Florida’s Medicaid bureaucrats seem to have thrown in the towel—at least for the moment—on the effort to give a single laboratory company an exclusive three-year contract to provide labora…
Review of 2004 Lab Sales Identifies Buyer Interest
By Robert Michel | From the Volume XII No. 3 – February 14, 2005 Issue
CEO SUMMARY: Laboratory acquisition activity was surprisingly high during 2004. One reason is that new buyers appeared in the marketplace. However, all buyers have specific acquisition criteria. When a selling lab meets that criteria, it can expect multiple bidders and a strong purchase p…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized